New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. New research shows that a needle-free mucosal bacteriophage ...
BioVenic offers one-stop solutions for veterinary vaccine development for protecting animals against various pathogen type.
Venigalla B. Rao, PhD, has been studying bacteriophages for more than four decades, mostly in small laboratories with limited personnel and funding. But having a mere eight-person lab (four post-docs, ...
Atomic structural model of bacteriophage T4 in UCSF Chimera software using pdbs of the individual proteins. Credit: Dr. Victor Padilla-Sanchez, PhD, CC BY-SA 4.0 Atomic structural model of ...
In a recent study published in the journal Nature Communications, researchers present a method for constructing artificial viral vectors (AVVs) using the established structural components of ...
Aims: Novel anticancer strategies have employed bacteriophages as drug carriers and display platforms for anticancer agents; however, bacteriophage-based platforms maintain their natural antibacterial ...
In a recent study posted to bioRxiv* preprint server, researchers developed a mucosal vaccine for coronavirus disease 2019 (COVID-19) based on bacteriophage. Vaccines against severe acute respiratory ...
“Mammalian cells actively engulf and traffic phages, so it’s important to understand the potential responses and impacts even if they are moderate to mild,” said Barr. To investigate the downstream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback